[Effect of STIL on the Gene Expression Profile of Gastric Cancer Cells]

Ju Wang1, Xia Zhong Dou1, Qiang Yong Wang1

  • 1Department of Gastrointestinal Surgery,Inner Mongolia Hospital,Hohhot 010017,China.

Insights

STIL gene silencing inhibits gastric cancer progression by affecting proteolysis and signaling pathways. This study identifies key molecular players like STUB1, SKP2, and FOXO1 in gastric carcinogenesis.

Area of Science:

  • Molecular biology
  • Genomics
  • Bioinformatics

Background:

  • Gastric cancer is a significant global health concern with complex molecular underpinnings.
  • Understanding the molecular mechanisms driving gastric carcinogenesis is crucial for developing targeted therapies.

Purpose of the Study:

  • To elucidate the molecular mechanisms of gastric cancer development and progression.
  • To identify key genes and pathways involved in gastric carcinogenesis using gene expression profiling and bioinformatics.

Main Methods:

  • Gene expression profiling array was employed on gastric cancer cells (SGC-7901) with STIL gene silencing.
  • Bioinformatic analyses included differential gene expression, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, transcription factor networks, and protein-protein interaction networks.

Main Results:

  • Silencing STIL resulted in significant down-regulation (417 genes) and up-regulation (87 genes) of gene expression.
  • Enrichment analyses revealed STIL-regulated genes are involved in ubiquitin-mediated proteolysis, the P53 signaling pathway, and stem cell pluripotency.
  • IGF1R, STUB1, SKP2, and FOXO1 were identified as central nodes in the regulatory network, crucial for gastric cancer progression.

Conclusions:

  • STIL promotes gastric carcinogenesis and progression potentially by activating E3 ubiquitin ligases (STUB1 or SKP2).
  • This activation may lead to the proteolysis of the transcription factor FOXO1 and subsequent regulation of IGF1R expression.
  • The identified molecular interactions highlight potential therapeutic targets for gastric cancer.